Canaccord Genuity Maintains Buy on Core Scientific, Raises Price Target to $36

Benzinga Newsdesk www.benzinga.com Positive 56.8%

Neg 0% Neu 0% Pos 56.8%

Canaccord Genuity analyst Joseph Vafi maintains Core Scientific (NASDAQ:CORZ) with a Buy and raises the price target from $30 to $36.